Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms

R. D. Hurt, K. P. Offord, Ivana T Croghan, G. A. Croghan, L. C. Gomez-Dahl, T. D. Wolter, L. C. Dale, T. P. Moyer

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91 cigarette smokers were randomly assigned to a single 1 mg dose of active nicotine nasal spray (n = 29), active 4 mg nicotine gum (n = 31), saline placebo nasal spray (n = 16) or placebo gum (n = 15). Following overnight abstinence, subjects repeatedly completed visual analog scales for assessing nicotine withdrawal symptoms over 30 min preceding (time -30 min to time 0) and 120 min following a single dose of study medication. This sequence was performed 3 times during the day. Nicotine withdrawal symptoms were assessed on a 41-point visual analog scale (1 = no withdrawal, 41 = extreme withdrawal). At the initial session only, blood samples for serum nicotine levels were taken at baseline, then at 5, 10, 30 and 120 min following study drug administration. The mean (± SD) age of the subjects was 38.6 (±10.1) years, 48% were females, smoking rate was 24.5 (±7.8) cigarettes per day, and years of smoking was 19.9 (±10.0). A single 1 mg dose of nicotine nasal spray provided more immediate relief for craving for a cigarette compared to a single 4 mg dose of nicotine gum. Serum venous nicotine levels for the active nicotine nasal spray and nicotine gum were comparable at 5 and 10 min while the levels were higher for nicotine gum at 30 and 120 min. Changes in withdrawal symptoms were not found to be related to serum venous nicotine levels. Our findings provide a rationale for the as needed use of nicotine nasal spray to control withdrawal symptoms, possibly in combination with other medications with longer acting effects.

Original languageEnglish (US)
Pages (from-to)98-104
Number of pages7
JournalPsychopharmacology
Volume140
Issue number1
DOIs
StatePublished - 1998

Fingerprint

Tobacco Use Cessation Products
Substance Withdrawal Syndrome
Gingiva
Nicotine
Tobacco Products
Visual Analog Scale
Smoking
Serum
Placebos
Single-Blind Method
Nasal Sprays

Keywords

  • Nicotine blood level
  • Nicotine gum
  • Nicotine nasal spray
  • Nicotine withdrawal symptom

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hurt, R. D., Offord, K. P., Croghan, I. T., Croghan, G. A., Gomez-Dahl, L. C., Wolter, T. D., ... Moyer, T. P. (1998). Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology, 140(1), 98-104. https://doi.org/10.1007/s002130050744

Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. / Hurt, R. D.; Offord, K. P.; Croghan, Ivana T; Croghan, G. A.; Gomez-Dahl, L. C.; Wolter, T. D.; Dale, L. C.; Moyer, T. P.

In: Psychopharmacology, Vol. 140, No. 1, 1998, p. 98-104.

Research output: Contribution to journalArticle

Hurt, RD, Offord, KP, Croghan, IT, Croghan, GA, Gomez-Dahl, LC, Wolter, TD, Dale, LC & Moyer, TP 1998, 'Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms', Psychopharmacology, vol. 140, no. 1, pp. 98-104. https://doi.org/10.1007/s002130050744
Hurt, R. D. ; Offord, K. P. ; Croghan, Ivana T ; Croghan, G. A. ; Gomez-Dahl, L. C. ; Wolter, T. D. ; Dale, L. C. ; Moyer, T. P. / Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. In: Psychopharmacology. 1998 ; Vol. 140, No. 1. pp. 98-104.
@article{849e92b3983e4dd0a886824c1ad6129f,
title = "Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms",
abstract = "Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91 cigarette smokers were randomly assigned to a single 1 mg dose of active nicotine nasal spray (n = 29), active 4 mg nicotine gum (n = 31), saline placebo nasal spray (n = 16) or placebo gum (n = 15). Following overnight abstinence, subjects repeatedly completed visual analog scales for assessing nicotine withdrawal symptoms over 30 min preceding (time -30 min to time 0) and 120 min following a single dose of study medication. This sequence was performed 3 times during the day. Nicotine withdrawal symptoms were assessed on a 41-point visual analog scale (1 = no withdrawal, 41 = extreme withdrawal). At the initial session only, blood samples for serum nicotine levels were taken at baseline, then at 5, 10, 30 and 120 min following study drug administration. The mean (± SD) age of the subjects was 38.6 (±10.1) years, 48{\%} were females, smoking rate was 24.5 (±7.8) cigarettes per day, and years of smoking was 19.9 (±10.0). A single 1 mg dose of nicotine nasal spray provided more immediate relief for craving for a cigarette compared to a single 4 mg dose of nicotine gum. Serum venous nicotine levels for the active nicotine nasal spray and nicotine gum were comparable at 5 and 10 min while the levels were higher for nicotine gum at 30 and 120 min. Changes in withdrawal symptoms were not found to be related to serum venous nicotine levels. Our findings provide a rationale for the as needed use of nicotine nasal spray to control withdrawal symptoms, possibly in combination with other medications with longer acting effects.",
keywords = "Nicotine blood level, Nicotine gum, Nicotine nasal spray, Nicotine withdrawal symptom",
author = "Hurt, {R. D.} and Offord, {K. P.} and Croghan, {Ivana T} and Croghan, {G. A.} and Gomez-Dahl, {L. C.} and Wolter, {T. D.} and Dale, {L. C.} and Moyer, {T. P.}",
year = "1998",
doi = "10.1007/s002130050744",
language = "English (US)",
volume = "140",
pages = "98--104",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms

AU - Hurt, R. D.

AU - Offord, K. P.

AU - Croghan, Ivana T

AU - Croghan, G. A.

AU - Gomez-Dahl, L. C.

AU - Wolter, T. D.

AU - Dale, L. C.

AU - Moyer, T. P.

PY - 1998

Y1 - 1998

N2 - Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91 cigarette smokers were randomly assigned to a single 1 mg dose of active nicotine nasal spray (n = 29), active 4 mg nicotine gum (n = 31), saline placebo nasal spray (n = 16) or placebo gum (n = 15). Following overnight abstinence, subjects repeatedly completed visual analog scales for assessing nicotine withdrawal symptoms over 30 min preceding (time -30 min to time 0) and 120 min following a single dose of study medication. This sequence was performed 3 times during the day. Nicotine withdrawal symptoms were assessed on a 41-point visual analog scale (1 = no withdrawal, 41 = extreme withdrawal). At the initial session only, blood samples for serum nicotine levels were taken at baseline, then at 5, 10, 30 and 120 min following study drug administration. The mean (± SD) age of the subjects was 38.6 (±10.1) years, 48% were females, smoking rate was 24.5 (±7.8) cigarettes per day, and years of smoking was 19.9 (±10.0). A single 1 mg dose of nicotine nasal spray provided more immediate relief for craving for a cigarette compared to a single 4 mg dose of nicotine gum. Serum venous nicotine levels for the active nicotine nasal spray and nicotine gum were comparable at 5 and 10 min while the levels were higher for nicotine gum at 30 and 120 min. Changes in withdrawal symptoms were not found to be related to serum venous nicotine levels. Our findings provide a rationale for the as needed use of nicotine nasal spray to control withdrawal symptoms, possibly in combination with other medications with longer acting effects.

AB - Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91 cigarette smokers were randomly assigned to a single 1 mg dose of active nicotine nasal spray (n = 29), active 4 mg nicotine gum (n = 31), saline placebo nasal spray (n = 16) or placebo gum (n = 15). Following overnight abstinence, subjects repeatedly completed visual analog scales for assessing nicotine withdrawal symptoms over 30 min preceding (time -30 min to time 0) and 120 min following a single dose of study medication. This sequence was performed 3 times during the day. Nicotine withdrawal symptoms were assessed on a 41-point visual analog scale (1 = no withdrawal, 41 = extreme withdrawal). At the initial session only, blood samples for serum nicotine levels were taken at baseline, then at 5, 10, 30 and 120 min following study drug administration. The mean (± SD) age of the subjects was 38.6 (±10.1) years, 48% were females, smoking rate was 24.5 (±7.8) cigarettes per day, and years of smoking was 19.9 (±10.0). A single 1 mg dose of nicotine nasal spray provided more immediate relief for craving for a cigarette compared to a single 4 mg dose of nicotine gum. Serum venous nicotine levels for the active nicotine nasal spray and nicotine gum were comparable at 5 and 10 min while the levels were higher for nicotine gum at 30 and 120 min. Changes in withdrawal symptoms were not found to be related to serum venous nicotine levels. Our findings provide a rationale for the as needed use of nicotine nasal spray to control withdrawal symptoms, possibly in combination with other medications with longer acting effects.

KW - Nicotine blood level

KW - Nicotine gum

KW - Nicotine nasal spray

KW - Nicotine withdrawal symptom

UR - http://www.scopus.com/inward/record.url?scp=0031759394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031759394&partnerID=8YFLogxK

U2 - 10.1007/s002130050744

DO - 10.1007/s002130050744

M3 - Article

C2 - 9862408

AN - SCOPUS:0031759394

VL - 140

SP - 98

EP - 104

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -